Today, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class ...
Axsome Therapeutics (AXSM) announced that the U.S. FDA has approved Symbravo for the acute treatment of migraine with or without aura in ...
Starting with the first Frontier Drive-In on Broadway, the cowboy has greeted diners from just about every marquee and menu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback